Afatinib-Associated Cutaneous Toxicity: A Correlation of Severe Skin Reaction with Dramatic Tumor Response in a Woman with Exon 19 Deletion Positive Non-Small-Cell Lung Cancer

Epidermal growth factor receptor (EGFR) inhibitors are biological factors used in the treatment of non-small-cell lung cancers (NSCLC) that are positive for EGFR mutations. Afatinib is one such drug that has been approved for use in this capacity. Cutaneous toxicity is the second most commonly repor...

Descripción completa

Detalles Bibliográficos
Autores principales: Osborn, Lindsay P, Cohen, Philip R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2016
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045329/
https://www.ncbi.nlm.nih.gov/pubmed/27725919
http://dx.doi.org/10.7759/cureus.763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045329/
https://www.ncbi.nlm.nih.gov/pubmed/27725919
http://dx.doi.org/10.7759/cureus.763

Ejemplares similares